SG149071A1 - Rhamnose promoter expression system - Google Patents

Rhamnose promoter expression system

Info

Publication number
SG149071A1
SG149071A1 SG200809642-2A SG2008096422A SG149071A1 SG 149071 A1 SG149071 A1 SG 149071A1 SG 2008096422 A SG2008096422 A SG 2008096422A SG 149071 A1 SG149071 A1 SG 149071A1
Authority
SG
Singapore
Prior art keywords
nucleic acid
acid sequence
promoter region
pseudomonas
host
Prior art date
Application number
SG200809642-2A
Other languages
English (en)
Inventor
Johann Brass
Christoph Kiziak
Joachim Klein
Ralf Ostendorp
Armin Weidmann
Original Assignee
Lonza Ag
Morphosys Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag, Morphosys Ag filed Critical Lonza Ag
Publication of SG149071A1 publication Critical patent/SG149071A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
SG200809642-2A 2004-12-07 2005-12-05 Rhamnose promoter expression system SG149071A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04028917 2004-12-07

Publications (1)

Publication Number Publication Date
SG149071A1 true SG149071A1 (en) 2009-01-29

Family

ID=36304177

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200809642-2A SG149071A1 (en) 2004-12-07 2005-12-05 Rhamnose promoter expression system

Country Status (14)

Country Link
US (3) US20080206817A1 (fr)
EP (2) EP2123761A3 (fr)
JP (1) JP5069124B2 (fr)
CN (1) CN101090969B (fr)
AT (1) ATE466090T1 (fr)
AU (1) AU2005313531B2 (fr)
CA (1) CA2589937C (fr)
DE (1) DE602005020972D1 (fr)
DK (1) DK1824980T3 (fr)
ES (1) ES2346894T3 (fr)
HK (1) HK1115156A1 (fr)
IL (1) IL183608A (fr)
SG (1) SG149071A1 (fr)
WO (1) WO2006061174A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2671264C (fr) 2006-11-30 2015-11-24 Research Development Foundation Bibliotheques d'immunoglobulines ameliorees
WO2009025888A2 (fr) 2007-05-10 2009-02-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Expression régulée d'antigène et/ou atténuation régulée pour accroître l'immunogénicité et/ou la sécurité de vaccins
ATE544860T1 (de) 2008-02-29 2012-02-15 Xbrane Bioscience Aktiebolag Expressionssystem für proteine
CN102978219B (zh) * 2012-11-09 2015-05-13 汕头大学 一种弧菌交叉保护性抗原及其制备方法和应用
US9911245B1 (en) * 2013-07-19 2018-03-06 Geotoll, Inc. Method and apparatus for using a vehicle license tag number for toll payment as a backup form of account authorization
CN106676125B (zh) * 2015-11-05 2020-08-14 中国科学院天津工业生物技术研究所 一种包含麦芽糖启动子的载体以及麦芽糖启动子突变体
WO2017149065A1 (fr) 2016-03-02 2017-09-08 Lonza Ltd Procédé de fermentation amélioré
EP3444269A1 (fr) 2017-08-17 2019-02-20 National Research Council of Canada Systèmes et méthodes pour la production de polypeptides de toxine diphterique
CN115698300A (zh) 2020-03-26 2023-02-03 阿斯克肋匹奥生物制药公司 佛司可林诱导型启动子和低氧诱导型启动子
EP4136237A1 (fr) 2020-04-15 2023-02-22 Asklepios Biopharmaceutical, Inc. Promoteurs inductibles par forskoline et promoteurs inductibles par hypoxie
EP3981879A1 (fr) * 2020-10-09 2022-04-13 Stada Arzneimittel Ag Procédé de production d'une protéine recombinante dans une cellule hôte qui possède un métabolisme du rhamnose désactivé ainsi que des vecteurs d'expression, cellules hôtes et protéines recombinantes associées
CA3232722A1 (fr) * 2021-09-24 2023-03-30 Kiavash MIRZADEH Constructions d'adn et cellules hotes pour exprimer une proteine recombinee

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650625T2 (de) 1985-01-28 1997-10-02 Xoma Corp AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren
JP2980626B2 (ja) * 1988-01-11 1999-11-22 ゾーマ・コーポレーション ペクチン酸リアーゼのシグナル配列を含む新規プラスミドベクター
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5240831A (en) * 1991-01-10 1993-08-31 Board Of Regents, The University Of Texas Methods and compositions for the expression of biologically active eukaryotic cytochrome p45os in bacteria
US5435128A (en) * 1993-11-15 1995-07-25 Thiokol Corporation Pyrotechnically driven nozzle restrictor
WO1998002462A1 (fr) 1996-07-16 1998-01-22 Morphosys Gesellschaft Für Proteinoptimierung Mbh Domaines de la superfamille des immunoglobulines et fragments presentant une solubilite accrue
US7094579B2 (en) 2002-02-13 2006-08-22 Xoma Technology Ltd. Eukaryotic signal sequences for prokaryotic expression
DK1570060T3 (da) 2002-12-02 2007-11-05 Basf Ag L-rhamnoseinducerbare ekspressionssystemer
WO2004063343A2 (fr) * 2003-01-09 2004-07-29 Macrogenics, Inc. Systeme vectoriel a double expression servant a exprimer des anticorps dans des cellules bacteriennes et mammiferes

Also Published As

Publication number Publication date
US20120135463A1 (en) 2012-05-31
EP2123761A2 (fr) 2009-11-25
US20080206817A1 (en) 2008-08-28
EP1824980A2 (fr) 2007-08-29
ATE466090T1 (de) 2010-05-15
AU2005313531A1 (en) 2006-06-15
HK1115156A1 (en) 2008-12-24
IL183608A (en) 2011-10-31
WO2006061174A3 (fr) 2007-01-18
JP2008522599A (ja) 2008-07-03
IL183608A0 (en) 2007-09-20
DE602005020972D1 (en) 2010-06-10
CA2589937C (fr) 2014-04-22
CN101090969A (zh) 2007-12-19
DK1824980T3 (da) 2010-08-16
AU2005313531B2 (en) 2011-04-14
JP5069124B2 (ja) 2012-11-07
US20170107525A1 (en) 2017-04-20
CN101090969B (zh) 2013-01-16
EP2123761A3 (fr) 2009-12-16
WO2006061174A2 (fr) 2006-06-15
EP1824980B1 (fr) 2010-04-28
CA2589937A1 (fr) 2006-06-15
ES2346894T3 (es) 2010-10-21
US9279128B2 (en) 2016-03-08

Similar Documents

Publication Publication Date Title
IL183608A0 (en) Rhamnose promoter expression system
TW200732472A (en) Method for the recombinant expression of a polypeptide
AU2590901A (en) Il-17 homologous polypeptides and therapeutic uses thereof
EP0722461A4 (fr) Expression de polypeptides de fusion transportes hors du cytoplasme sans sequence de tete
ATE509943T1 (de) Peptidreinigung mittels metallionenaffinitätschromatographie
WO1999060127A3 (fr) Polypeptides homologues de il-17 et utilisations therapeutiques de ceux-ci
WO2002000711A3 (fr) Acides nucleiques ev-vegf et polypeptides et leurs procedes d'utilisation
RU99124196A (ru) Прямая экспрессия пептидов в культуральные среды
AU3774300A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2003008437A3 (fr) Systemes d'expression de proteines et d'acides nucleiques
WO2003042362A3 (fr) Pgc-1$g(b), un nouvel homologue du pgc-1 et leurs utilisations
DK1905839T3 (da) Fremgangsmåde til fermentativ fremstilling af proteiner
WO2006061173A3 (fr) Systeme d'expression de l'operon de la melibiose
WO2009112587A3 (fr) Variation de titres d'expression recombinante par optimisation de sites de liaison à des ribosomes bactériens
GR3026465T3 (en) Biosynthetic process for the preparation of proteins.
WO2001098453A3 (fr) Vecteurs d'expression comprenant un fragment modifie de l'operon tryptophane
WO2000052164A3 (fr) Nouvelles molecules du canal potassique et leur utilisation
WO2003070768A3 (fr) Variants d'epissage cd40, compositions de fabrication et procedes d'utilisation de ceux-ci
WO2004087886A3 (fr) Constructions adenovirales e1a modifiees et procedes d'utilisation
EP0750040A3 (fr) Variants de la protéine stimulatrice des macrophages et procédés de fabrication
WO2001032872A3 (fr) Nouvelles molecules canal potassium et utilisations de celles-ci
WO2000043419A3 (fr) Proteine de voies d'exocytose et leurs procedes d'utilisation
AU2001253258A1 (en) Human trp-like calcium channel protein-2 (tlcc-2)
WO2001077329A3 (fr) 12303, molecule twik humaine et utilisations correspondantes
AU2001263920A1 (en) Method for the production of proteins in a yeast of the genusarxula and suitable promoters